Ads
related to: hyperphosphatemia treatment guidelines chart pdf- Dosing & Administration
Phosphate Control With Flexible
Dosing For Patients On Dialysis.
- Access Information
Visit To Find Access Information
For A Hyperphosphatemia Treatment.
- Phosphate Binder Info
Phosphate Binder For Dialysis
Patients With Hyperphosphatemia.
- Watch An MOA Video
Phosphate Binder Potency Info
For Your Patients.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Hyperphosphatemia. Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood. [1] Most people have no symptoms while others develop calcium deposits in the soft tissue. [1] The disorder is often accompanied by low calcium blood levels, which can result in muscle spasms.
Sucroferric oxyhydroxide. Sucroferric oxyhydroxide, sold under the brand name Velphoro, is a non-calcium, iron-based phosphate binder used for the control of serum phosphorus levels in adults with chronic kidney disease (CKD) on haemodialysis (HD) or peritoneal dialysis (PD). [6] It is used in form of chewable tablets.
Phosphate binder. Phosphate binders are medications used to reduce the absorption of dietary phosphate; they are taken along with meals and snacks. They are frequently used in people with chronic kidney failure (CKF), who are less able to excrete phosphate, resulting in an elevated serum phosphate.
Phosphate binders, supplementary calcium [ 3 ] Named after. Fuller Albright. Albright's hereditary osteodystrophy is a form of osteodystrophy, [ 4 ] and is classified as the phenotype of pseudohypoparathyroidism type 1A; this is a condition in which the body does not respond to parathyroid hormone. [ 1 ]
Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer ...
Vitamin D deficiency is typically diagnosed by measuring the concentration of the 25-hydroxyvitamin D in the blood, which is the most accurate measure of stores of vitamin D in the body. [1][7][2] One nanogram per millilitre (1 ng/mL) is equivalent to 2.5 nanomoles per litre (2.5 nmol/L). Severe deficiency: <12 ng/mL = <30 nmol/L[2] Deficiency ...
Rare (1 in 100,000); [3] more common in some populations [4] Hypophosphatasia (/ ˌhaɪpoʊˈfɒsfeɪtˌeɪʒə /; also called deficiency of alkaline phosphatase, phosphoethanolaminuria, [5] or Rathbun's syndrome; [1] sometimes abbreviated HPP[6]) is a rare, and sometimes fatal, inherited [7] metabolic bone disease. [8]
Other names. Mabry syndrome. This condition is inherited in an autosomal recessive manner. Hyperphosphatasia with mental retardation syndrome, HPMRS, [1] also known as Mabry syndrome, [2] has been described in patients recruited on four continents world-wide. [3] Mabry syndrome was confirmed [4] to represent an autosomal recessive syndrome ...
Ads
related to: hyperphosphatemia treatment guidelines chart pdf